BGS: Belgian Glaucoma Society

View entire schedule

Visual field / Free papers

Symposium

Thursday 24 November 2011, 08:25 - 12:05, Hall B

Moderators

Michèle DETRY, Marc GOETHALS

	08:25	Welcome
	08:30	Correlation of the rate of progression of visual field loss between Guided Progression Analysis (GPA II) and PeriDataTM program in glaucoma patients: Pilot study		PEETERS H, DETRY- MOREL M, POURJAVAN S
	08:40	Differential effects of various VEGF isoforms on endothelial cells and Tenon fibroblasts		VAN BERGEN T, VANDEWALLE E, VAN DE VEIRE S, MOONS L, STALMANS I
	08:50	The effect of a single, preoperative, intracameral administration of bevacizumab (Avastin®) on trabeculectomy outcome: A prospective, randomized, double-blinded, placebo-controlled trial.		VANDEWALLE E, ZEYEN T, VAN BERGEN T, SPIELBERG L, STALMANS I
	09:00	FRO: Identity-by-descent mapping reveals a new locus for primary congenital glaucoma, GLC3E, on chromosome 19p13.2.		VERDIN H, D'HAENE B, COPPIETERS F, LEFEVER S, KESTELYN P, LEROY B, DE BAERE E
	09:10	FRO: Microplasmin as an antiscarring agent for glaucoma surgery: Translation into clinical application		VANDEWALLE E, VAN BERGEN T, MOONS L, STALMANS I
	09:20	FRO: Role of placental growth factor (PIGF) in wound healing after glaucoma filtration surgery		VAN BERGEN T, MOONS L, STASSEN JM, STALMANS I
	09:30	Topical application of AMA0076, a locally acting rho kinase (ROCK) inhibitor, results in a robust IOP control in a hypertensive rabbit model		VAN DE VELDE S, MOONS L, STALMANS I
	09:40	Pfizer Research Award 2011
	09:50	Basic principles of automated perimetry		KESTELYN P
	10:00	Tips for the perimetrist		VAN MALDEREN L
	10:10	Interpretation of the results		COLLIGNON N
	10:30	Break
	11:00	Pitfalls		HOSTE A
	11:10	Detecting progression		ZEYEN T
	11:20	Linking function to structure		STALMANS I
	11:30	Driver licence: how to apply the new rules		STEVENS AM
	11:40	Challenging clinical cases
	12:05	End of session